Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10773/35368 |
Resumo: | Adverse drug reactions (ADR) significantly impact mortality and morbidity and lead to high healthcare costs. Reporting ADR to regulatory authorities allows for monitoring the safety and efficacy profile of medicines on the market and for assessing the benefit-risk ratio. This retrospective study aims to characterize the ADR profile of the most consumed antibiotics in Portugal that are prescribed for upper airway infections and submitted to the EudraVigilance database. The variables were analyzed in an exploratory perspective, through absolute and relative frequencies, with emphasis on serious ADR. A total of 59,022 reports were analyzed of which 64.4% were classified as suspected serious ADR. According to serious ADR, the female sex (52.2%) and 18-64 age group (47.5%) prevail. Health professionals reported 87.8% of suspected serious ADR and European Economic Area (EEA) countries represented 50.8% of the reports. "Skin and subcutaneous tissue connections" (15.9%), "general disorders and administrations site conditions" (12%), and "gastrointestinal disorders" (9.8%) are the prevalent system organ classes. In 4.5% of the reports, patients had a fatal outcome. A periodic evaluation of the safety of the antibiotic should be performed to facilitate the development of guidelines and policies to reduce the frequency of serious ADR. |
id |
RCAP_1ce303615df7e355535d791f9fc91511 |
---|---|
oai_identifier_str |
oai:ria.ua.pt:10773/35368 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infectionsAdverse drug reactionsAntibioticsUpper airway infectionsEudraVigilance databaseAdverse drug reactions (ADR) significantly impact mortality and morbidity and lead to high healthcare costs. Reporting ADR to regulatory authorities allows for monitoring the safety and efficacy profile of medicines on the market and for assessing the benefit-risk ratio. This retrospective study aims to characterize the ADR profile of the most consumed antibiotics in Portugal that are prescribed for upper airway infections and submitted to the EudraVigilance database. The variables were analyzed in an exploratory perspective, through absolute and relative frequencies, with emphasis on serious ADR. A total of 59,022 reports were analyzed of which 64.4% were classified as suspected serious ADR. According to serious ADR, the female sex (52.2%) and 18-64 age group (47.5%) prevail. Health professionals reported 87.8% of suspected serious ADR and European Economic Area (EEA) countries represented 50.8% of the reports. "Skin and subcutaneous tissue connections" (15.9%), "general disorders and administrations site conditions" (12%), and "gastrointestinal disorders" (9.8%) are the prevalent system organ classes. In 4.5% of the reports, patients had a fatal outcome. A periodic evaluation of the safety of the antibiotic should be performed to facilitate the development of guidelines and policies to reduce the frequency of serious ADR.MDPI2022-11-30T15:58:15Z2022-04-02T00:00:00Z2022-04-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10773/35368eng10.3390/antibiotics11040477Ferreira, JoanaPlacido, Ana IsabelAfreixo, VeraRibeiro-Vaz, InêsRoque, FátimaHerdeiro, Maria Teresainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T12:07:59Zoai:ria.ua.pt:10773/35368Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:06:21.936284Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
title |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
spellingShingle |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections Ferreira, Joana Adverse drug reactions Antibiotics Upper airway infections EudraVigilance database |
title_short |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
title_full |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
title_fullStr |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
title_full_unstemmed |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
title_sort |
Descriptive analysis of adverse drug reactions reports of the most consumed antibiotics in Portugal, prescribed for upper airway infections |
author |
Ferreira, Joana |
author_facet |
Ferreira, Joana Placido, Ana Isabel Afreixo, Vera Ribeiro-Vaz, Inês Roque, Fátima Herdeiro, Maria Teresa |
author_role |
author |
author2 |
Placido, Ana Isabel Afreixo, Vera Ribeiro-Vaz, Inês Roque, Fátima Herdeiro, Maria Teresa |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Ferreira, Joana Placido, Ana Isabel Afreixo, Vera Ribeiro-Vaz, Inês Roque, Fátima Herdeiro, Maria Teresa |
dc.subject.por.fl_str_mv |
Adverse drug reactions Antibiotics Upper airway infections EudraVigilance database |
topic |
Adverse drug reactions Antibiotics Upper airway infections EudraVigilance database |
description |
Adverse drug reactions (ADR) significantly impact mortality and morbidity and lead to high healthcare costs. Reporting ADR to regulatory authorities allows for monitoring the safety and efficacy profile of medicines on the market and for assessing the benefit-risk ratio. This retrospective study aims to characterize the ADR profile of the most consumed antibiotics in Portugal that are prescribed for upper airway infections and submitted to the EudraVigilance database. The variables were analyzed in an exploratory perspective, through absolute and relative frequencies, with emphasis on serious ADR. A total of 59,022 reports were analyzed of which 64.4% were classified as suspected serious ADR. According to serious ADR, the female sex (52.2%) and 18-64 age group (47.5%) prevail. Health professionals reported 87.8% of suspected serious ADR and European Economic Area (EEA) countries represented 50.8% of the reports. "Skin and subcutaneous tissue connections" (15.9%), "general disorders and administrations site conditions" (12%), and "gastrointestinal disorders" (9.8%) are the prevalent system organ classes. In 4.5% of the reports, patients had a fatal outcome. A periodic evaluation of the safety of the antibiotic should be performed to facilitate the development of guidelines and policies to reduce the frequency of serious ADR. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-30T15:58:15Z 2022-04-02T00:00:00Z 2022-04-02 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10773/35368 |
url |
http://hdl.handle.net/10773/35368 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.3390/antibiotics11040477 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137718905602048 |